Open AccessEvaluation of type 2 diabetes treatment with gliclazide modified release in Azerbaijan (the EdiAzer study): Results from a 16-week observational clinical study
Author(s) -
Valeh Mirzazada,
Ramila A Huseynova,
Sevil A Mustafayeva,
F.N. Gasimova,
Ulviyya Ahmadova,
Narmin Ismayilova,
Vafa Kerimova,
Hagigat Mehdiyeva,
R.R. Suleymanova,
Zahrakhanim Maharramova,
Gulnara Iskandarli,
Ofeliya Gurbanova,
Sariyya Aghayeva,
Sabina Malikova,
Konul Ismayilova,
Khanim Salimkhanova
Publication year - 2020
Publication title -
journal of diabetology
Language(s) - English
Resource type - Journals
eISSN - 2543-3288
pISSN - 2078-7685
DOI - 10.4103/jod.jod_5_20
Subject(s) - gliclazide , medicine , metformin , glycated hemoglobin , type 2 diabetes , diabetes mellitus , overweight , clinical endpoint , adverse effect , observational study , type 2 diabetes mellitus , gastroenterology , obesity , endocrinology , clinical trial